{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:34:12Z","timestamp":1791419652608,"version":"4.3.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/00639"],"award-info":[{"award-number":["PI16\/00639"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010552","name":"Departament de Salut, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["SLT002\/16\/00058"],"award-info":[{"award-number":["SLT002\/16\/00058"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002943","name":"Departament d'Innovaci\u00f3, Universitats i Empresa, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["SGR 578"],"award-info":[{"award-number":["SGR 578"]}],"id":[{"id":"10.13039\/501100002943","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The implementation of individual clinical practice guidelines in patients with multimorbidity often results in polypharmacy. Our aim was to analyse medication use according to longitudinal multimorbidity patterns (MP) and determine during a 5-year period (2012\u201316) which MP are associated with abnormal liver and kidney function in primary care patients over 65\u2009years of age living in Catalonia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Design<\/jats:italic>\n                      : Longitudinal study (years 2012 to 2016) based on the electronic health records contained in Information System for Research in Primary Care database of the Catalan Institute of Health (SIDIAP).\n                      <jats:italic>Variables<\/jats:italic>\n                      : age, sex, MP, medication and polypharmacy (drug exposure obtained from the Pharmacy Invoice Registry). Medicines were classified in accordance with the Anatomical Therapeutic Chemical Classification System (ATC). Glomerular filtration rate was used to determine abnormal kidney function, and serum levels of alkaline phosphatase, alanine transaminase and gamma-glutamyl transpeptidase were used to diagnose abnormal liver function.\n                      <jats:italic>Statistics<\/jats:italic>\n                      : For medication use in MP, we calculated annual mean packages of each drug in each MP, and observed\/expected ratios were obtained by dividing mean packages in the cluster by mean packages of the same drug in the overall population. Logistic regression models were fitted to estimate the association between MP at baseline and abnormal kidney and liver function tests during follow up.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nine hundred sixteen thousand six hundred nineteen patients were included, and 743,827 completed the follow up. We identified one polypharmacy profile per MP, and concluded that the most prescribed drugs in each pattern corresponded to the diseases overrepresented in that specific MP. The median of drugs ranged from 3 (Cluster 1 - Non-Specific) to 8 (Cluster 10 - Multisystem Pattern). Abnormal kidney function was most commonly observed in the Cluster 4 - Cardio-Circulatory and Renal (Odds Ratio [OR] 2.19; Confidence interval [CI] 95% 2.15\u20132.23) and Cluster 3 - Minority Metabolic Autoimmune-Inflammatory (OR 2.16; CI 95% 2.12\u20132.20) MP. A higher risk of abnormal liver function was observed in the Cluster 8 - Digestive (OR 3.39; CI 95% 3.30\u20133.49), and Cluster 4 - Cardio-Circulatory and Renal (OR 1.96; CI 95% 1.91\u20132.02) MP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A higher risk of abnormal kidney and liver function was observed in specific MP. The long-term characterisation of MP and polypharmacy illustrates the burden of chronic multimorbidity and polypharmacy in the elderly population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12877-020-01580-1","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T06:03:45Z","timestamp":1591941825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Multimorbidity patterns, polypharmacy and their association with liver and kidney abnormalities in people over 65\u2009years of age: a longitudinal study"],"prefix":"10.1186","volume":"20","author":[{"given":"Noem\u00ed","family":"Vill\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Guisado-Clavero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Fern\u00e1ndez-Bertol\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Troncoso-Mari\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quint\u00ed","family":"Foguet-Boreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Amado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariona","family":"Pons-Vigu\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Roso-Llorach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3309-5360","authenticated-orcid":false,"given":"Concepci\u00f3n","family":"Viol\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"issue":"4","key":"1580_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1370\/afm.983","volume":"7","author":"JM Valderas","year":"2009","unstructured":"Valderas JM, Starfi B, Sibbald B. Understanding health and health services. Ann Fam Med. 2009;7(4):357\u201363.","journal-title":"Ann Fam Med"},{"issue":"10033","key":"1580_CR2","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/S0140-6736(15)00516-4","volume":"387","author":"JR Beard","year":"2016","unstructured":"Beard JR, Officer A, de Carvalho IA, Sadana R, Pot AM, Michel J-P, et al. The world report on ageing and health: a policy framework for healthyageing. Lancet. 2016;387(10033):2145\u201354.","journal-title":"Lancet"},{"issue":"582","key":"1580_CR3","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.3399\/bjgp11X548929","volume":"61","author":"C Salisbury","year":"2011","unstructured":"Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery A. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2011;61(582):e12\u201321.","journal-title":"Br J Gen Pract"},{"issue":"4","key":"1580_CR4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.arr.2011.03.003","volume":"10","author":"A Marengoni","year":"2011","unstructured":"Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10(4):430\u20139.","journal-title":"Ageing Res Rev"},{"issue":"7","key":"1580_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1371\/journal.pone.0102149","volume":"9","author":"C Violan","year":"2014","unstructured":"Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One. 2014;9(7):3\u201311.","journal-title":"PLoS One"},{"key":"1580_CR6","doi-asserted-by":"publisher","first-page":"e6341","DOI":"10.1136\/bmj.e6341","volume":"345","author":"B Guthrie","year":"2012","unstructured":"Guthrie B, Payne K, Alderson P, McMurdo MET, Mercer SW. Adapting clinical guidelines to take account of multimorbidity. BMJ. 2012;345:e6341.","journal-title":"BMJ."},{"key":"1580_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? systematic review of definitions. BMC Geriatr. 2017;17:230.","journal-title":"BMC Geriatr"},{"issue":"12","key":"1580_CR8","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00228-015-1954-4","volume":"71","author":"E Tommelein","year":"2015","unstructured":"Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K. Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol. 2015;71(12):1415\u201327.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"1580_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1517\/14740338.2013.827660","volume":"13","author":"RL Maher","year":"2014","unstructured":"Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57\u201365.","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"1580_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.amjopharm.2007.12.002","volume":"5","author":"ER Hajjar","year":"2007","unstructured":"Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345\u201351.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"4","key":"1580_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/cr.2017.18","volume":"27","author":"R Ren","year":"2017","unstructured":"Ren R, Deng L, Xue Y, Suzuki K, Zhang W, Yu Y, et al. Visualization of aging-associated chromatin alterations with an engineered TALE system. Cell Res. 2017;27(4):483\u2013504.","journal-title":"Cell Res"},{"issue":"6","key":"1580_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2174\/092986710790416326","volume":"17","author":"A Corsonello","year":"2010","unstructured":"Corsonello A, Pedone C, Incalzi R. Age-related pharmacokinetic and Pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem. 2010;17(6):571\u201384.","journal-title":"Curr Med Chem"},{"issue":"2","key":"1580_CR13","first-page":"101","volume":"5","author":"N Poulose","year":"2014","unstructured":"Poulose N, Raju R. Aging and injury: alterations in cellular energetics and organ function. Aging Dis. 2014;5(2):101\u20138.","journal-title":"Aging Dis"},{"key":"1580_CR14","first-page":"CD008165","volume":"9","author":"A Rankin","year":"2018","unstructured":"Rankin A, Cadogan CA, Patterson SM, Kerse N, Cardwell CR, Bradley MC, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018;9:CD008165.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1580_CR15","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jclinepi.2013.09.021","volume":"67","author":"A Prados-Torres","year":"2014","unstructured":"Prados-Torres A, Calder\u00f3n-Larra\u00f1aga A, Hancco-Saavedra J, Poblador-Plou B, Van Den Akker M. Multimorbidity patterns: a systematic review. J Clin Epidemiol. 2014;67(3):254\u201366.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1580_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12875-019-0969-9","volume":"20","author":"M Guisado-Clavero","year":"2019","unstructured":"Guisado-Clavero M, Viol\u00e1n C, L\u00f3pez-Jimenez T, Roso-Llorach A, Pons-Vigu\u00e9s M, Mu\u00f1oz MA, et al. Medication patterns in older adults with multimorbidity: a cluster analysis of primary care patients. BMC Fam Pract. 2019;20(1):1\u201312.","journal-title":"BMC Fam Pract"},{"issue":"1","key":"1580_CR17","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1038\/s41598-018-21917-6","volume":"8","author":"T Aoki","year":"2018","unstructured":"Aoki T, Yamamoto Y, Ikenoue T, Onishi Y, Fukuhara S. Multimorbidity patterns in relation to polypharmacy and dosage frequency: a nationwide, cross-sectional study in a Japanese population. Sci Rep. 2018;8(1):3806.","journal-title":"Sci Rep"},{"issue":"12","key":"1580_CR18","doi-asserted-by":"publisher","first-page":"e84967","DOI":"10.1371\/journal.pone.0084967","volume":"8","author":"A Calder\u00f3n-Larra\u00f1aga","year":"2013","unstructured":"Calder\u00f3n-Larra\u00f1aga A, Gimeno-Feliu LA, Gonz\u00e1lez-Rubio F, Poblador-Plou B, Lairla-San Jos\u00e9 M, Abad-D\u00edez JM, et al. Polypharmacy patterns: Unravelling systematic associations between prescribed medications. PLoS One. 2013;8(12):e84967.","journal-title":"PLoS One"},{"key":"1580_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejim.2018.07.014","volume":"55","author":"K Kostev","year":"2018","unstructured":"Kostev K, Jacob L. Multimorbidity and polypharmacy among elderly people followed in general practices in Germany. Eur J Intern Med. 2018;55:66\u20138.","journal-title":"Eur J Intern Med"},{"key":"1580_CR20","unstructured":"Viol\u00e1n C, Fern\u00e1ndez-Bertol\u00edn S, Guisado-Clavero M, Foguet-Boreu Q, Valderas JM, Vidal J, et al. Longitudinal multimorbidity patterns in elderly population using hidden Markov models: a cohort study of Mediterranean elderly population. Sci Rep."},{"key":"1580_CR21","unstructured":"Statistical Institute of Catalonia. Idescat. Statistical Yearbook of Catalonia [Internet]. 2016 [cited 2019 Dec 9]. Available from: http:\/\/www.idescat.cat\/pub\/?id=aec&lang=en."},{"key":"1580_CR22","unstructured":"Mem\u00f2ria d\u2019activitats 2012. Institut Catal\u00e0 de la Salut [Internet]. 2012 [cited 2019 Nov 18]. Available from: http:\/\/ics.gencat.cat\/ca\/detall\/publicacio\/memoria_2012-00007."},{"issue":"3","key":"1580_CR23","first-page":"135","volume":"19","author":"M Garc\u00eda-Gil","year":"2011","unstructured":"Garc\u00eda-Gil M, Hermosilla E, Prieto-Alhambra D, Fina F, Rosell M, Ramos R, et al. Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP). Inform Prim Care. 2011;19(3):135\u201345.","journal-title":"Inform Prim Care"},{"issue":"10","key":"1580_CR24","first-page":"1417","volume":"72","author":"A Calder\u00f3n-Larra\u00f1aga","year":"2017","unstructured":"Calder\u00f3n-Larra\u00f1aga A, Vetrano DL, Onder G, Gimeno-Feliu LA, Coscollar-Santaliestra C, Carf\u00ed A, et al. Assessing and measuring chronic multimorbidity in the older population: a proposal for its operationalization. J Gerontol - Ser A Biol Sci Med Sci. 2017;72(10):1417\u201323.","journal-title":"J Gerontol - Ser A Biol Sci Med Sci"},{"key":"1580_CR25","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2013. 16th ed. Oslo: 2013. https:\/\/www.whocc.no\/filearchive\/publications\/1_2013guidelines.pdf."},{"issue":"4","key":"1580_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.hipert.2012.07.005","volume":"29","author":"JM Elorza-Ricart","year":"2012","unstructured":"Elorza-Ricart JM, Tovillas-Mor\u00e1n FJ, Oliveras-Puig A, Galcer\u00e1n JM, Fina F, Dalf\u00f3-Baqu\u00e9 A. Estudio transversal comparativo de las f\u00f3rmulas CKD-EPI y MDRD-4 a partir de la historia cl\u00ednica informatizada de Atenci\u00f3n Primaria de Barcelona. Hipertens y Riesgo Vasc. 2012;29(4):118\u201329.","journal-title":"Hipertens y Riesgo Vasc"},{"issue":"7","key":"1580_CR27","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/pds.4803","volume":"28","author":"J Forns","year":"2019","unstructured":"Forns J, Cainzos-Achirica M, Hellfritzsch M, Morros R, Poblador-Plou B, Hallas J, et al. Validity of ICD-9 and ICD-10 codes used to identify acute liver injury: a study in three European data sources. Pharmacoepidemiol Drug Saf. 2019;28(7):965\u201375.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"1580_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1157\/13123961","volume":"22","author":"MF Dom\u00ednguez-Berj\u00f3n","year":"2008","unstructured":"Dom\u00ednguez-Berj\u00f3n MF, Borrell C, Cano-Serral G, Esnaola S, Nolasco A, Pasar\u00edn MI, et al. Construcci\u00f3n de un \u00edndice de privaci\u00f3n a partir de datos censales en grandes ciudades espa\u00f1olas (Proyecto MEDEA). Gac Sanit. 2008;22(3):179\u201387.","journal-title":"Gac Sanit"},{"key":"1580_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-0450-1","volume-title":"Pattern recognition with fuzzy objective function algorithms","author":"JC Bezdek","year":"1981","unstructured":"Bezdek JC. Pattern recognition with fuzzy objective function algorithms. 1st ed. New York. Springer: Plenum Press; 1981.","edition":"1"},{"issue":"2","key":"1580_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1109\/5.18626","volume":"77","author":"LR Rabinier","year":"1989","unstructured":"Rabinier LR. A tutorial on hidden Markov models and selected applications in speech recognition. Proc IEEE. 1989;77(2):257\u201386.","journal-title":"Proc IEEE"},{"issue":"4","key":"1580_CR31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377\u201399.","journal-title":"Stat Med"},{"key":"1580_CR32","volume-title":"Polypharmacy and medicines optimisation making it safe and sound [internet]","author":"M Duerden","year":"2013","unstructured":"Duerden M, Avery T, Payne R. Polypharmacy and medicines optimisation making it safe and sound [internet]. London: The King\u2019s Fund; 2013. Available from: https:\/\/www.kingsfund.org.uk\/sites\/default\/files\/field\/field_publication_file\/polypharmacy-and-medicines-optimisation-kingsfund-nov13.pdf."},{"key":"1580_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009235","volume":"5","author":"JA Cooper","year":"2015","unstructured":"Cooper JA, Cadogan CA, Patterson SM, Kerse N, Bradley MC, Ryan C, et al. Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review. BMJ Open. 2015;5:e009235.","journal-title":"BMJ Open"},{"issue":"2","key":"1580_CR34","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1001\/jamainternmed.2018.5748","volume":"179","author":"DJ Morgan","year":"2019","unstructured":"Morgan DJ, Dhruva SS, Coon ER, Wright SM, Korenstein D. 2018 update on medical overuse. JAMA Intern Med. 2019;179(2):240\u20136.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"1580_CR35","doi-asserted-by":"publisher","first-page":"196","DOI":"10.7861\/clinmedicine.18-3-196","volume":"18","author":"HJ Woodford","year":"2018","unstructured":"Woodford HJ, Barrett S, Pattman S. Vitamin D: too much testing and treating? Clin Med (Northfield Il). 2018;18(3):196\u2013200.","journal-title":"Clin Med (Northfield Il)"},{"issue":"10","key":"1580_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/bmjopen-2016-012463","volume":"6","author":"M Mata-Cases","year":"2016","unstructured":"Mata-Cases M, Franch-Nadal J, Real J, Mauricio D. Glycaemic control and antidiabetic treatment trends in primary care centres in patients with type 2 diabetes mellitus during 2007-2013 in Catalonia: a population-based study. BMJ Open. 2016;6(10):4\u201311.","journal-title":"BMJ Open"},{"issue":"4","key":"1580_CR37","doi-asserted-by":"publisher","first-page":"468","DOI":"10.2337\/dc16-0985","volume":"40","author":"KJ Lipska","year":"2017","unstructured":"Lipska KJ, Yao X, Herrin J, McCoy RG, Ross JS, Steinman MA, et al. Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006-2013. Diabetes Care. 2017;40(4):468\u201375.","journal-title":"Diabetes Care"},{"issue":"2","key":"1580_CR38","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/ki.2015.101","volume":"88","author":"T Dreischulte","year":"2015","unstructured":"Dreischulte T, Morales DR, Bell S, Guthrie B. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and\/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury. Kidney Int. 2015;88(2):396\u2013403.","journal-title":"Kidney Int"},{"key":"1580_CR39","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","volume":"382","author":"C Baigent","year":"2013","unstructured":"Baigent C, Bhala N, Emberson J, Merhi A, Abramson S, Arber N, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382:769\u201379.","journal-title":"Lancet"},{"key":"1580_CR40","doi-asserted-by":"publisher","first-page":"i4857","DOI":"10.1136\/bmj.i4857","volume":"354","author":"A Arf\u00e8","year":"2016","unstructured":"Arf\u00e8 A, Scotti L, Varas-Lorenzo C, Nicotra F, Zambon A, Kollhorst B, et al. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ. 2016;354:i4857.","journal-title":"BMJ"},{"key":"1580_CR41","unstructured":"Bosch JA, Calb\u00e9 JJ, Calero F, D\u00edaz JM, Diego L, Esmatjes E, et al. Pautes per a l\u2019harmonitzaci\u00f3 del tractament farmacol\u00f2gic de la malal\u01bda renal cr\u00f2nica. Barcelona: Ag\u00e8ncia de Qualitat i Avaluaci\u00f3 Sanit\u00e0ries de Catalunya (AQuAS). Departament de Salut. Generalitat de Catalunya; 2016."},{"issue":"1","key":"1580_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.22516\/25007440.71","volume":"31","author":"ML Morales","year":"2016","unstructured":"Morales ML, V\u00e9lez LN, Mu\u00f1oz M. OG. Hepatotoxicidad: Patr\u00f3n colest\u00e1sico inducido por f\u00e1rmacos. Rev Colomb Gastroenterol. 2016;31(1):36\u201347.","journal-title":"Rev Colomb Gastroenterol"},{"issue":"3","key":"1580_CR43","first-page":"177","volume":"3","author":"F Tejada","year":"2010","unstructured":"Tejada F. Hepatotoxicidad por farmacos. Rev Cl\u00ednica Med Fam. 2010;3(3):177\u201391.","journal-title":"Rev Cl\u00ednica Med Fam"},{"issue":"4","key":"1580_CR44","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1530\/EJE-08-0837","volume":"160","author":"P Iglesias","year":"2009","unstructured":"Iglesias P, D\u00edez JJ. Thyroid dysfunction and kidney disease. Eur J Endocrinol. 2009;160(4):503\u201315.","journal-title":"Eur J Endocrinol"},{"key":"1580_CR45","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2147\/CLEP.S153458","volume":"10","author":"L Morin","year":"2018","unstructured":"Morin L, Johnell K, Laroche ML, Fastbom J, Wastesson JW. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol. 2018;10:289\u201398.","journal-title":"Clin Epidemiol"},{"key":"1580_CR46","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0140-6736(16)32585-5","volume":"390","author":"S Brownlee","year":"2017","unstructured":"Brownlee S, Chalkidou K, Doust J, Elshaug AG, Glasziou P, Heath I, et al. Evidence for overuse of medical services around the world. Lancet. 2017;390:156\u201368.","journal-title":"Lancet."},{"issue":"2","key":"1580_CR47","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jama.2015.7517","volume":"314","author":"A Benetos","year":"2015","unstructured":"Benetos A, Rossignol P, Cherubini A, Joly L, Grodzicki T, Rajkumar C, et al. Polypharmacy in the aging patient: Management of Hypertension in octogenarians. J Am Med Assoc. 2015;314(2):170\u201380.","journal-title":"J Am Med Assoc"}],"updated-by":[{"DOI":"10.1186\/s12877-021-02567-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000}}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-020-01580-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-020-01580-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-020-01580-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T08:24:51Z","timestamp":1651825491000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-020-01580-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1580"],"URL":"https:\/\/doi.org\/10.1186\/s12877-020-01580-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-23421\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-23421\/v2","asserted-by":"object"}]},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,12]]},"assertion":[{"value":"11 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12877-021-02567-2","URL":"https:\/\/doi.org\/10.1186\/s12877-021-02567-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol of the study was approved by the Clinical Research Ethics Committee, Fundaci\u00f3 Institut Universitari per a la recerca a l\u2019Atenci\u00f3 Prim\u00e0ria de Salut Jordi Gol i Gurina (IDIAPJGol) (P16\/151). All data were anonymized in agreement with national and international law.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have completed the ICMJE uniform disclosure form at\n                      \n                      and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could have influenced the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"206"}}